Norges Bank Makes New $17.46 Million Investment in CRISPR Therapeutics AG (NASDAQ:CRSP)
Norges Bank acquired a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 443,536 shares of the company’s stock, valued at approximately $17,458,000. Norges Bank owned about 0.52% of CRISPR Therapeutics as of its most recent filing with […]
Norges Bank acquired a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 443,536 shares of the company’s stock, valued at approximately $17,458,000. Norges Bank owned about 0.52% of CRISPR Therapeutics as of its most recent filing with […]
